Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Go check out CEO
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(948)
•••
Comment by Nailbiter2on Jan 09, 2023 11:40am
137 Views
Post# 35211204

RE:Go check out CEO

RE:Go check out CEO
Liked2Think wrote: And see Nails talking about amazon and bed, bath, and beyond

the moron goes to a stagezero board and talks about other companies.

clear sign there is nothing to talk about here

I guess thats the excuse for the pumpers.  Bed, bath, and beyond isnt doing well so how do you expect a cancer testing company to do well either?  BBAB doing bad in 2023 is the same as Stage doing bad the past 2 years! 

duhhhhhhh

Not too bright are you?
Try following the thread of the conversation on CEO.CA
and give your head a shake.

Hector Salamanca GIF - Hector Salamanca Breaking - Discover & Share GIFs

@WHATTHE @Nailbiter what's your take here? The market is not happy with this? What say you?
 
0
 
@Nailbiter The market is sour grapes everywhere.
 
0
 
@Nailbiter Grand Poobah Amazon to send walking papers to over 18,000 workers. Sh!t gettin' real.
 
0
 
@Nailbiter BB and Beyond could chapter 13. 57,000 jobs gone. What's hittin' the fan?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities